(Downloading may take up to 30 seconds.
If the slide opens in your browser, select File -> Save As to save it.)

Click on image to view larger version.


Figure 6


Fig. 6. PrPC-Vn interaction supports axonal growth in DRG from E12.5 mouse embryos. ZrchI Prnp+/+ (a-d) and ZrchI Prnp0/0 (e-g) DRG were cultured on poly-L-lysine-coated coverslips (c), 200 nM Vn (a and g), 0.4 µM peptide Vn307-320Mo (b and f), 0.4 µM peptide Vn161-174 (d and e) and Vn plus anti-recombinant PrPC antibody 13 µg/ml or Vn plus irrelevant IgG 13 µg/ml (h). Inset dark-field image in a shows a DRG subjected to anti-PrPC immunohistochemistry. (h) Comparison of mean axonal growth per DRG from ZrchI Prnp+/+ (white bars) and Prnp0/0 mice (grey bars) for the conditions described above. *P<0.001 vs Pll control, Tukey's Test. (i) Comparison of mean axonal growth per DRG of at least 12 ganglia from Npu Prnp+/+ (striped bars) and Prnp–/– mice (black bars) for each of the following conditions: Pll, 200 nM Vn, 0.2 or 0.4 µM Vn307-320Mo, 0.4 µM Vn161-174, Vn plus irrelevant IgG or 0.6 µg/ml anti-PrPC peptide 106-126. *P<0.001 vs Pll control, Tukey's Test. (j) The percentage of cells from ZrchI Prnp+/+ (white bars) and ZrchI Prnp0/0 (grey bars) dissociated DRG neurons that grow axons increased with increasing concentrations of Vn; *P<0.001 vs Pll control, Tukey's test.